EGFR and colorectal carcinoma: Indeed, in a randomized controlled trial, Nuñez-Sánchez et al. [46] demonstrated that ellagitannin-containing pomegranate extract supplementation altered the expression of cancer-related genes (e.g., CD44, CTNNB1, and EGFR) in colon tissues from CRC patients.